Victory Capital Management
PCVX icon

Victory Capital Management’s Vaxcyte PCVX Stock Holding History

Victory Capital Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.3M Sell
452,723
-49,134
-10% -$2.67M 0.01% 815
2026
Q1 		$29.2M Sell
501,857
-47,657
-9% -$2.59M 0.02% 739
2025
Q4 		$25.4M Buy
549,514
+234,622
+75% +$10.5M 0.01% 797
2025
Q3 		$11.3M Sell
314,892
-135,727
-30% -$4.5M 0.01% 1066
2025
Q2 		$14.7M Buy
450,619
+229,800
+104% +$7.53M 0.01% 987
2025
Q1 		$8.34M Sell
220,819
-82,737
-27% -$6.62M 0.01% 1118
2024
Q4 		$24.8M Buy
303,556
+48,516
+19% +$4.82M 0.02% 761
2024
Q3 		$29.1M Sell
255,040
-52,476
-17% -$4.73M 0.03% 685
2024
Q2 		$23.2M Buy
307,516
+26,641
+9% +$1.81M 0.02% 751
2024
Q1 		$19.2M Sell
280,875
-98,532
-26% -$6.82M 0.02% 834
2023
Q4 		$23.8M Sell
379,407
-51,542
-12% -$2.68M 0.03% 712
2023
Q3 		$22M Sell
430,949
-31,355
-7% -$1.55M 0.03% 715
2023
Q2 		$23.1M Buy
462,304
+69,055
+18% +$3.27M 0.03% 720
2023
Q1 		$14.7M Buy
393,249
+325,536
+481% +$13.8M 0.02% 891
2022
Q4 		$3.25M Buy
67,713
+11,693
+21% +$459K ﹤0.01% 1309
2022
Q3 		$1.34M Sell
56,020
-17,610
-24% -$446K ﹤0.01% 1603
2022
Q2 		$1.6M Sell
73,630
-15,380
-17% -$356K ﹤0.01% 1541
2022
Q1 		$2.15M Buy
+89,010
New +$1.94M ﹤0.01% 1473
2020
Q4 		– Sell
-5,102
Closed -$252K – 2574
2020
Q3 		$252K Buy
+5,102
New +$203K ﹤0.01% 2222

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Victory Capital Management's PCVX Position: Q2 2026 in Review

Victory Capital Management reduced its Vaxcyte (PCVX) stake by 9.8% in Q2 2026, selling an estimated $2.67M and leaving 452,723 shares worth $26.3M. The position accounts for 0.01% of the portfolio, ranked #815.

Victory Capital Management first reported a position in PCVX in Q3 2020 and has held it in 19 quarters since. The position peaked at $29.2M in Q1 2026. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Victory Capital Management held 452,723 shares of Vaxcyte worth $26.3M as of Q2 2026.
  • Victory Capital Management sold 49,134 Vaxcyte shares in Q2 2026, an estimated $2.67M.
  • Vaxcyte made up 0.01% of Victory Capital Management's portfolio in Q2 2026, its #815 holding.
  • Victory Capital Management first reported a position in Vaxcyte in Q3 2020 and has held it in 19 quarters since.
  • Victory Capital Management's Vaxcyte position peaked at $29.2M in Q1 2026.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.